Monthly archives for January, 2021
Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
DERIVATIVE STRATEGY – BUDGET 2021 by HDFC Sec | |
Company: | Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | January 29, 2021 |
Type of Report: | Techno-Funda |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | DERIVATIVE STRATEGY – FOR CONSERVATIVE TRADERS |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Derivative strategies, HDFC Sec, Union Budget |
EIH Limited Research Report By Nirmal Bang | |
Company: | EIH |
Brokerage: | Nirmal Bang |
Date of report: | January 16, 2021 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 19% |
Summary: | Reduced pandemic impact, cyclical upswing, strong brand and locational advantage to drive growth |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | EIH, Nirmal Bang |
Kolte Patil Developers Ltd (Mohnish Pabrai High-Conviction Portfolio Stock) Research Report By Edleweiss | |
Company: | Kolte-Patil Developers |
Brokerage: | Edelweiss |
Date of report: | January 10, 2021 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 17% |
Summary: | Scaling up for next leg of growth |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Edelweiss, Kolte-Patil Developers |
Phillips Carbon Black Research Report By ICICI-Direct | |
Company: | Phillips Carbon Black |
Brokerage: | ICICI-Direct |
Date of report: | January 6, 2021 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 22% |
Summary: | ADD ruled out, fundamental demand drivers stay intact |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | ICICI-Direct, Phillips Carbon Black |
Alembic Pharmaceuticals Research Report By IIFL | |
Company: | Alembic Pharma |
Brokerage: | IIFL |
Date of report: | January 6, 2021 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 20% |
Summary: | Strong all-round earnings |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Alembic Pharma, IIFL |
Polycab India Research Report By Prabhudas Lilladher | |
Company: | Polycab India |
Brokerage: | Prabhudas Lilladher |
Date of report: | January 5, 2021 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 21% |
Summary: | Evolving into a formidable FMEG player |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Polycab India, Prabhudas Lilladher |
RBL Bank Research Report By CLSA | |
Company: | RBL Bank |
Brokerage: | CLSA |
Date of report: | January 5, 2021 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 38% |
Summary: | Building scale in profitable segments; initiate with BUY |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | CLSA, RBL Bank |
Huhtamaki India Research Report By ICICI Direct | |
Company: | Huhtamaki India |
Brokerage: | ICICI-Direct |
Date of report: | January 1, 2021 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 21% |
Summary: | Innovator in flexible packaging industry… |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Huhtamaki India, ICICI-Direct |
Sumitomo Chemicals India Ltd Research Report By Nirmal Bang | |
Company: | Motherson Sumi |
Brokerage: | Nirmal Bang |
Date of report: | January 1, 2021 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 18.6% |
Summary: | Emerging MNC proxy in Indian CPC growth story |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Nirmal Bang, Sumitomo Chemicals |
Top Stocks To Buy For 2021 By Axis Securities | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | January 1, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | 2021: A year of resuscitation of growth |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Axis Securities, Model Portfolio |